These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26138471)

  • 1. Emerging drugs for preeclampsia--the endothelium as a target.
    Sasser JM; Murphy SR; Granger JP
    Expert Opin Emerg Drugs; 2015; 20(4):527-30. PubMed ID: 26138471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothesis: selective phosphodiesterase-5 inhibition improves outcome in preeclampsia.
    Downing JW; Ramasubramanian R; Johnson RF; Minzter BH; Paschall RL; Sundell HW; Engelhardt B; Lewis R
    Med Hypotheses; 2004; 63(6):1057-64. PubMed ID: 15504576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential targets for the treatment of preeclampsia.
    Oyston CJ; Stanley JL; Baker PN
    Expert Opin Ther Targets; 2015; 19(11):1517-30. PubMed ID: 26389556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug development in preeclampsia: a 'no go' area?
    Everett TR; Wilkinson IB; Lees CC
    J Matern Fetal Neonatal Med; 2012 Jan; 25(1):50-2. PubMed ID: 21391756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphodiesterase Inhibition in the Treatment of Preeclampsia: What Is New?
    Larré AB; Sontag F; Pasin DM; Paludo N; do Amaral RR; da Costa BEP; Poli-de-Figueiredo CE
    Curr Hypertens Rep; 2018 Jul; 20(10):83. PubMed ID: 30051151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upcoming drugs for the treatment of preeclampsia in pregnant women.
    Ornaghi S; Paidas MJ
    Expert Rev Clin Pharmacol; 2014 Sep; 7(5):599-603. PubMed ID: 25068820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
    Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
    Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Endothelin Type A Receptor as a Potential Therapeutic Target in Preeclampsia.
    Bakrania B; Duncan J; Warrington JP; Granger JP
    Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28264495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypertension and pregnancy. Diagnosis, physiopathology and treatment].
    Fournier A; Fievet P; el Esper I; el Esper N; Vaillant P; Gondry J
    Schweiz Med Wochenschr; 1995 Nov; 125(47):2273-98. PubMed ID: 8539576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular dysfunction in preeclampsia.
    Brennan LJ; Morton JS; Davidge ST
    Microcirculation; 2014 Jan; 21(1):4-14. PubMed ID: 23890192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension in pregnancy: the most recent findings in pathophysiology, diagnosis and therapy.
    Zezza L; Ralli E; Conti E; Passerini J; Autore C; Caserta D
    Minerva Ginecol; 2014 Feb; 66(1):103-26. PubMed ID: 24569409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms and potential therapies for preeclampsia.
    George EM; Granger JP
    Curr Hypertens Rep; 2011 Aug; 13(4):269-75. PubMed ID: 21465139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of sildenafil on the altered thoracic aorta smooth muscle responses in rat pre-eclampsia model.
    Turgut NH; Temiz TK; Bagcivan I; Turgut B; Gulturk S; Karadas B
    Eur J Pharmacol; 2008 Jul; 589(1-3):180-7. PubMed ID: 18538317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preeclampsia as a maternal vascular disease].
    Amash A; Huleihel M; Sheiner E; Sapir O; Holcberg G
    Harefuah; 2007 Sep; 146(9):707-12, 733. PubMed ID: 17969310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preeclampsia as a cause of preterm and late preterm (near-term) births.
    Sibai BM
    Semin Perinatol; 2006 Feb; 30(1):16-9. PubMed ID: 16549208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sildenafil for the treatment of preeclampsia, an update: should we still be enthusiastic?
    Simon-Tillaux N; Lecarpentier E; Tsatsaris V; Hertig A
    Nephrol Dial Transplant; 2019 Nov; 34(11):1819-1826. PubMed ID: 30403811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sildenafil preserves lung endothelial function and prevents pulmonary vascular remodeling in a rat model of diastolic heart failure.
    Yin J; Kukucka M; Hoffmann J; Sterner-Kock A; Burhenne J; Haefeli WE; Kuppe H; Kuebler WM
    Circ Heart Fail; 2011 Mar; 4(2):198-206. PubMed ID: 21216837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sildenafil Treatment Ameliorates the Maternal Syndrome of Preeclampsia and Rescues Fetal Growth in the Dahl Salt-Sensitive Rat.
    Gillis EE; Mooney JN; Garrett MR; Granger JP; Sasser JM
    Hypertension; 2016 Mar; 67(3):647-53. PubMed ID: 26729752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial dysfunction in the human umbilical artery due to preeclampsia can be prevented by sildenafil.
    Karasu E; Kayacan N; Sadan G; Dinc B
    Clin Exp Hypertens; 2012; 34(2):79-85. PubMed ID: 22251377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endothelial dysfunction: role in the maternal syndrome of preeclampsia and long-term consequences for the cardiovascular system].
    Calicchio R; Buffat C; Vaiman D; Miralles F
    Ann Cardiol Angeiol (Paris); 2013 Jun; 62(3):215-20. PubMed ID: 23721989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.